Montreal, October 2016 – As part of the partnership between Desjardins – Innovatech and the Health Technology Campus (CTS), an investment of $ 250,000 is granted by Desjardins – Innovatech to Biomomentum inc. The objective is to increase the commercialization of a range of high-performance mechanical testers for the characterization of biomaterials and biological tissues while offering mechanical testing services in the laboratory.

According to Martin Garon, President of Biomomentum, “this investment by Desjardins-Innovatech and the support of CTS come at the right time to support our ambitious international marketing projects for our medical instruments. ”

“CTS and Desjardins – Innovatech are investing in the future with Biomomentum, supports Guillaume Hervé, Chairman of CTS. The specialization of the company opens the doors of the international market that we wish to conquer with an adapted development process. ”

The Biomomentum team includes Eric Quenneville, Chief Executive Officer, and Martin Garon, President. The 2010 winners of the Quebec Entrepreneurship Contest and winners of the 2011 Entrepreneurship Prize (Desjardins & Cie), these entrepreneurs have the expertise, the passion and the desire to energize this field.

Biomomentum aspires to become a world leader in its sector by developing and marketing two innovative devices. First, the arthroscopic Arthro-BST â„¢ probe used for the accurate and non-destructive evaluation of articular cartilage to calculate a quantitative parameter that reflects the biochemical composition and mechanical properties of the cartilage. Then the Mach-1 â„¢, a multiaxial mechanical tester that can perform tests in compression, tension, shear and torsion for precise characterization or mechanical stimulation of cartilage or other soft tissues or materials.

The objective of the intervention of DESJARDINS – INNOVATECH, through the CTS and the investment of $ 250,000, is to strengthen the marketing effort, in order to complete a new phase of marketing development at the international level for their products and services having already demonstrated their commercial potential.

 

About Biomomentum

Biomomentum is specialize in providing solutions for the biomechanical evaluation of tissues, biomaterials and cartilage. The company develops and markets Arthro-BST â„¢, an arthroscopic probe used for the accurate, non-destructive evaluation of articular cartilage. The device calculates a quantitative parameter that reflects the biochemical composition and carrier properties of the cartilage. Biomomentum also develops and markets the Mach-1 â„¢, a multiaxial mechanical tester capable of performing compression, tension, shear and torsion tests for the precise characterization and mechanical stimulation of cartilage and other soft tissues or materials. In addition, Biomomentum offers unique biomechanical testing services.

 

 About CTS

CTS is an accelerator of companies in the field of medical technologies which offers them to develop faster and increases their chances of success. The goal of the CTS is to offer start-up companies a unique proposition with structured framework that allows them to focus on developing their technology, reaching market dynamics and gaining the visibility they need to start and develop internationally.

 

About Desjardins – Innovatech

Created in 2005, the Desjardins – Innovatech fund was created by the initiative of the Government of Québec and Capital régional et coopératif Desjardins. With more than $ 55 million invested in nearly 40 companies and funds, Desjardins – Innovatech’s main mission is to promote and support companies from Quebec, who involved in the development of technological innovation or Industrialists and the new generation of Quebec innovation entrepreneurs, with their capital financing. In order to fulfill its mission, the fund joins forces with other players in the technological field – specialized investment funds, entrepreneurs, financial angels, technological company’s accelerators – contributing to increase PME in terms of job creation and economic development.

 

For additional information (journalists only)

Biomomentum

Martin Garon

President

1 450 667-2299

garon@biomomentum.com

 

 

CTS

Romain Lortille Bruel

Director of Business Development

514-274-1001 or 514-808-9775

Lortillebruel@ctssante.ca

 

Desjardins – Innovatech

Richard Lacasse

Media spokesperson

418-835-8444 or 1-866-835-8444, ext. 556 3163

Media@desjardins.com

Menu